Research indicates that HIV product p17 upregulates the expression of the EBV latency-specific product LMP-1 and that its accumulation in tumor tissues targets CXC chemokine receptor 2 (CXCR2) to enhance B-cell clonality [78]. The gene discussed is CXCR2; the disease is neoplasm.